Treatment blood pressure targets for hypertension

  • Protocol
  • Intervention

Authors

  • Jose Agustin Arguedas,

    Corresponding author
    1. Universidad de Costa Rica, Depto de Farmacologia Clinica, Facultad de Medicina, San Pedro de Montes de Oca, Costa Rica
    • Jose Agustin Arguedas, Depto de Farmacologia Clinica, Facultad de Medicina, Universidad de Costa Rica, San Pedro de Montes de Oca, Costa Rica. drarguedas@ampmd.com.

    Search for more papers by this author
  • Marco I Perez,

    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada
    Search for more papers by this author
  • James M Wright

    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The main objective of this systematic review is to determine if there is a therapeutic advantage associated with setting a target blood pressure of 135/85 mmHg or below as compared to the higher target blood pressure of 140 to 160 mmHg systolic or 90 to 100 mmHg diastolic. The therapeutic advantage requires a significant reduction in the health outcomes listed below.